| Primary |
| Drug Use For Unknown Indication |
30.2% |
| Diabetes Mellitus |
11.4% |
| Product Used For Unknown Indication |
10.9% |
| Type 2 Diabetes Mellitus |
10.7% |
| Type 1 Diabetes Mellitus |
9.0% |
| Diabetes Mellitus Insulin-dependent |
6.1% |
| Insulin-requiring Type 2 Diabetes Mellitus |
4.9% |
| Hypertension |
3.9% |
| Foetal Exposure During Pregnancy |
2.2% |
| Drug Exposure During Pregnancy |
1.7% |
| Epilepsy |
1.2% |
| Atrial Fibrillation |
1.0% |
| Colitis |
1.0% |
| Hyperuricaemia |
1.0% |
| Myocardial Ischaemia |
1.0% |
| Renal Failure Chronic |
1.0% |
| Diabetic Ketoacidosis |
0.7% |
| Hyperglycaemia |
0.7% |
| Off Label Use |
0.7% |
| Pregnancy |
0.7% |
|
| Hypoglycaemia |
19.2% |
| Death |
6.4% |
| Completed Suicide |
5.1% |
| Premature Baby |
5.1% |
| Renal Failure |
5.1% |
| Syncope |
5.1% |
| Dyspnoea |
3.8% |
| Emergency Care |
3.8% |
| Hepatic Steatosis |
3.8% |
| Hypokalaemia |
3.8% |
| Injection Site Erythema |
3.8% |
| Myocardial Infarction |
3.8% |
| Pre-eclampsia |
3.8% |
| Pregnancy |
3.8% |
| Premature Labour |
3.8% |
| Psychomotor Retardation |
3.8% |
| Respiratory Failure |
3.8% |
| Respiratory Tract Malformation |
3.8% |
| Sudden Death |
3.8% |
| Suicide Attempt |
3.8% |
|
| Secondary |
| Drug Use For Unknown Indication |
39.9% |
| Product Used For Unknown Indication |
13.2% |
| Type 1 Diabetes Mellitus |
9.1% |
| Diabetes Mellitus |
8.4% |
| Hypertension |
8.1% |
| Type 2 Diabetes Mellitus |
6.2% |
| Pain |
2.0% |
| Diabetes Mellitus Insulin-dependent |
1.4% |
| Foetal Exposure During Pregnancy |
1.4% |
| Depression |
1.2% |
| Insulin-requiring Type 2 Diabetes Mellitus |
1.2% |
| Cardiac Failure |
1.1% |
| Benign Prostatic Hyperplasia |
0.9% |
| Hiv Infection |
0.9% |
| Hypercholesterolaemia |
0.9% |
| Arrhythmia |
0.8% |
| Arthralgia |
0.8% |
| Off Label Use |
0.8% |
| Prophylaxis |
0.8% |
| Systemic Antiviral Treatment |
0.8% |
|
| Toxic Epidermal Necrolysis |
11.1% |
| Pregnancy |
9.9% |
| Toxic Skin Eruption |
9.9% |
| Hypoglycaemia |
8.6% |
| Premature Baby |
8.6% |
| Stevens-johnson Syndrome |
6.2% |
| Hypoglycaemic Seizure |
4.9% |
| Product Quality Issue |
4.9% |
| Death |
3.7% |
| Intentional Overdose |
3.7% |
| Osteoarthritis |
3.7% |
| Psychomotor Retardation |
3.7% |
| Withdrawal Syndrome |
3.7% |
| Abortion Induced |
2.5% |
| Abscess |
2.5% |
| Agranulocytosis |
2.5% |
| Completed Suicide |
2.5% |
| Dermatitis Exfoliative |
2.5% |
| Malaise |
2.5% |
| Peripheral Vascular Disorder |
2.5% |
|
| Concomitant |
| Drug Use For Unknown Indication |
28.7% |
| Product Used For Unknown Indication |
21.2% |
| Hypertension |
11.8% |
| Diabetes Mellitus |
9.3% |
| Prophylaxis |
3.5% |
| Type 2 Diabetes Mellitus |
3.5% |
| Rheumatoid Arthritis |
3.0% |
| Sedation |
2.5% |
| Pain |
2.3% |
| Thrombosis Prophylaxis |
1.7% |
| Infection |
1.6% |
| Supplementation Therapy |
1.4% |
| Insulin-requiring Type Ii Diabetes Mellitus |
1.3% |
| Coronary Artery Disease |
1.3% |
| Pneumonia |
1.3% |
| Depression |
1.2% |
| Premedication |
1.2% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.1% |
| Hyperlipidaemia |
1.0% |
| Chronic Obstructive Pulmonary Disease |
1.0% |
|
| Renal Failure Acute |
10.8% |
| Thrombocytopenia |
8.5% |
| Pulmonary Embolism |
7.7% |
| Vomiting |
7.3% |
| Sepsis |
6.5% |
| Pyrexia |
5.4% |
| Wound Infection |
5.4% |
| Goitre |
4.6% |
| Death |
4.2% |
| Myocardial Infarction |
4.2% |
| Rectal Haemorrhage |
4.2% |
| Hypotension |
3.8% |
| Renal Failure |
3.8% |
| Shock |
3.8% |
| Drug Ineffective |
3.5% |
| Toxic Epidermal Necrolysis |
3.5% |
| Ventricular Fibrillation |
3.5% |
| Diabetes Mellitus |
3.1% |
| Pancytopenia |
3.1% |
| Rhabdomyolysis |
3.1% |
|
| Interacting |
| Cardiac Failure |
22.2% |
| Type 2 Diabetes Mellitus |
22.2% |
| Constipation |
11.1% |
| Coronary Artery Disease |
11.1% |
| Diabetic Neuropathy |
11.1% |
| Hyperuricaemia |
11.1% |
| Renal Failure |
11.1% |
|
|
